Filtered By:
Source: Atherosclerosis
Countries: Canada Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1 results found since Jan 2013.

Lipoprotein(a) variability over time in adult lipid clinic patients
Lipoprotein(a) (Lp[a]) is a low-density lipoprotein (LDL)-like particle in which apolipoprotein (apo) B is covalently bound to a plasminogen-like molecule called apo(a) [1]. Elevated plasma Lp(a) concentration is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD), including myocardial infarction, stroke and cardiac death [1]. The European Atherosclerosis Society, European Society of Cardiology and Canadian Cardiovascular Society (CCS) dyslipidemia guidelines recommend measurement of Lp(a) once in an individual's lifetime to identify patients with high levels who would benefit from earlier, more i...
Source: Atherosclerosis - September 5, 2022 Category: Cardiology Authors: Isabel Shamsudeen, Robert A. Hegele Tags: Correspondence Source Type: research